Back to JACOBS LEVY EQUITY MANAGEMENT, INC JACOBS LEVY EQUITY MANAGEMENT, INC

DSGNDSGN
Showing 8 of 13 quarters

Position history for JACOBS LEVY EQUITY MANAGEMENT, INCJACOBS LEVY EQUITY MANAGEMENT, INC's holdings in DESIGN THERAPEUTICS INC

JACOBS LEVY EQUITY MANAGEMENT, INC holds 565,597 shares of DSGN (DESIGN THERAPEUTICS INC), worth $8.2M as of 2026-Q2. The position was increased (+95.5% shares). DSGN represents 0.0% of JACOBS LEVY EQUITY MANAGEMENT, INC's portfolio.

Current Value

$8.2M

Current Shares

565,597

Total Value Change

+$6.7M

Total Shares Change

+285,326

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
565,597
+95.5%
$8.2M0.0%$14.47
44
2026-Q1
Increased
289,385
+48.7%
$3.1M0.0%$10.00
36
2025-Q4
New
194,611
-
$1.8M0.0%$9.79
36
2025-Q3
Exited
0
-100.0%
$00.0%$6.85
0
2025-Q2
Decreased
13,501
-22.8%
$45,4980.0%$3.57
0
2025-Q1
Decreased
17,482
-4.3%
$67,4810.0%$4.21
0
2024-Q4
Decreased
18,261
-93.5%
$112,6700.0%$6.17
0
2024-Q3
Decreased
280,271
-41.1%
$1.5M0.0%$5.33
0

Other major holders of DSGN: CITADEL ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., Point72 Asset Management, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used